Literature DB >> 35909638

Race-Ethnic Differences of ST-Elevation Myocardial Infarction: Findings from a New York Health System Registry.

Christopher S G Murray1, Cristian Zamora2, Sanyog G Shitole3, Panagiota Christa2, Un Jung Lee2, Anna E Bortnick1, Jorge R Kizer4, Carlos J Rodriguez2.   

Abstract

Background: Race and ethnicity are major considerations in the incidence, management, and long-term outcome of ST-elevation myocardial infarction (STEMI) in the United States, but there is limited existing comparative data.
Methods: We assembled a registry in a health system serving Bronx, NY of STEMI patients from 2008-2014 and analyzed differences in presentation, treatment and mortality between Hispanic/Latino (H/L), non-Hispanic Black (NHB) and non-Hispanic White (NHW). Upon discharge post-treatment for STEMI, all patients were followed for a median of 4.4 years (interquartile range 2.5, 6.0). Out of 966 STEMI patients, mean age was 61 years, 46% were H/L and 65% were male. H/Ls and NHBs had a higher prevalence of hypertension and diabetes mellitus than their NHW counterparts, coinciding with a lower socioeconomic status (SES).
Results: The number of critically diseased vessels found at cardiac catheterization and mean troponin levels did not vary by race-ethnicity; neither did the adjusted hazard ratios (HR) for death. However, age-sex adjusted rates of general hospital readmission were higher in NHBs vs NHWs (HR 1.30, P=.03). Age-sex adjusted cardiovascular readmissions rates were higher in H/Ls than NHWs (HR 1.42, P=.03). Age-sex adjusted heart failure readmissions were increased for both H/Ls (HR 2.14, P=.01) and NHBs (HR 2.12, P=.02) over NHWs. Conclusions: Among STEMI patients, a higher prevalence of modifiable cardiovascular risk factors and a lower SES was seen among NHBs and H/Ls compared to NHWs. Despite similar coronary disease severity and in-hospital death, NHBs and H/Ls had a greater risk of general, cardiovascular and heart failure readmissions post-STEMI compared to NHWs.
Copyright © 2022, Ethnicity & Disease, Inc.

Entities:  

Keywords:  Outcomes; Race-Ethnic Differences; STEMI

Mesh:

Year:  2022        PMID: 35909638      PMCID: PMC9311301          DOI: 10.18865/ed.32.3.193

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   2.006


  32 in total

1.  Ethnic variations in acute coronary syndromes.

Authors:  G A Lanza
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 2.  Ethnic and Racial Disparities in Acute Myocardial Infarction.

Authors:  Steven Simon; P Michael Ho
Journal:  Curr Cardiol Rep       Date:  2020-07-09       Impact factor: 2.931

Review 3.  CVD risk factors and ethnicity--a homogeneous relationship?

Authors:  Nita G Forouhi; Naveed Sattar
Journal:  Atheroscler Suppl       Date:  2006-02-24       Impact factor: 3.235

4.  Neighborhood of residence and incidence of coronary heart disease.

Authors:  A V Diez Roux; S S Merkin; D Arnett; L Chambless; M Massing; F J Nieto; P Sorlie; M Szklo; H A Tyroler; R L Watson
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

5.  Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry).

Authors:  James Slater; Faith Selzer; Sharmila Dorbala; Deborah Tormey; Helen A Vlachos; Robert L Wilensky; Alice K Jacobs; Warren K Laskey; John S Douglas; David O Williams; Sheryl F Kelsey
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

6.  Differences in utilization of drug-eluting stents by race and payer.

Authors:  Edward L Hannan; Michael Racz; Gary Walford; Luther T Clark; David R Holmes; Spencer B King; Samin Sharma
Journal:  Am J Cardiol       Date:  2007-08-02       Impact factor: 2.778

7.  Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.

Authors:  Koon-Hou Mak; Deepak L Bhatt; Mingyuan Shao; Graeme J Hankey; J Donald Easton; Keith A A Fox; Eric J Topol
Journal:  Am Heart J       Date:  2008-11-06       Impact factor: 4.749

8.  Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case-control study.

Authors:  Victoria Karetnikova; Olga Gruzdeva; Evgenya Uchasova; Anastasia Osokina; Olga Barbarash
Journal:  BMC Endocr Disord       Date:  2016-06-01       Impact factor: 2.763

Review 9.  Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes.

Authors:  Ferdinando Carlo Sasso; Luca Rinaldi; Nadia Lascar; Aldo Marrone; Pia Clara Pafundi; Luigi Elio Adinolfi; Raffaele Marfella
Journal:  J Diabetes Res       Date:  2018-10-04       Impact factor: 4.011

10.  Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.

Authors:  Anjan K Chakrabarti; Priyamvada Singh; Lakshmi Gopalakrishnan; Varun Kumar; Meagan Elizabeth Doherty; Cassandra Abueg; Weici Wang; C Michael Gibson
Journal:  Cardiol Res Pract       Date:  2012-07-09       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.